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Background
Transient gene expression (TGE) is a multi-parametric
process which is built upon four essential influencing pil-
lars: First of all, it is imperative to have an easy to trans-
fect cell line which allows high product titers and is
cultivated in suspension [1]. Secondly, only a few of the
commercially available cell culture media allow/support
transient transfection and production. Thus, it is highly
recommended to select the appropriate medium to grow
and transfect the favored cell line [2]. Thirdly, the quality,
source and backbone of the plasmid DNA which contains
the genetic information for the protein of interest has a
major impact [3]. Last but not least, to introduce plasmid
DNA into mammalian cells, selection of a suited trans-
fection reagent plays an important role for high-yielding
TGE processes.
In this work, we summarize our recent development of a
novel TGE system for efficient transient transfection and
expression in HEK cells. In cooperation with emp Biotech,
InVivo BioTech Services developed a transfection reagent
with very low cytotoxicity. A culture medium that can be
used for transfection and production was designed in col-
laboration with Xell AG. The establishment of a TGE opti-
mized HEK cell line (HEK-INV) and a method for large
scale plasmid preparation of a corresponding vector com-
plete the optimized production platform. It is easy applic-
able, scalable and supports large scale transfection for the
production of gram quantities of IgG within a few days.
Materials and methods
Mammalian cells were cultivated and transfected in
Xellvivo TM medium (Cat. No. 861-0001, Xell AG)
under conditions of 37 °C, 5 % CO2 and 185 rpm agita-
tion speed at 50 mm orbital diameter. For screening
approaches 5x10E6 cells/mL were transfected with 2 pg
DNA/cell and INVect transfection reagent (Cat. No.
FK-0101-M001.0-001, emp Biotech GmbH) with INVect
to DNA ratio of 6:1 (w/w) or 25 kDa L-PEI with PEI to
DNA ration of 2:1 (w/w) in 8 mL culture volume in
50 mL bioreactor tubes. Expression of IgG1 was per-
formed in 30 mL culture volume in 125 mL shake flasks
or in 150 mL culture volume in 500 mL shake flasks
respectively. Yields were quantified by proteinA affinity
chromatography. Directed evolution was performed
referring to Majors et al., 2009 [4]. In detail, an iterative
process of evolution rounds followed by analysis of
favorable attributes, cell selection and recovery was
implemented. The corresponding flow cytometry analy-
sis was performed using a Bio-Rad S3 cell sorter.
Several E.coli strains and media were screened for
high productivity, high quality and flexibility for DNA
preparation in comparison to commercial kits in mini-
preparation scale. A purification process was implemen-
ted using a reusable and scalable anion exchanger. For
large scale plasmid preparation, 6 L suspension was
lysed, clarified and purified using an Äktaprime chroma-
tography system. DoE was used for TGE process optimi-
zation after combining all developed elements.
Results
At least two plasmids were compared using different
E. coli strains cultivated in three different media in regards
to yield and quality aspects. Quality attributes such as the
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amount of supercoiled monomeric DNA highly depended
on the host strains, whereas absolute yield was found to be
a function of the cultivation medium. Additionally, a puri-
fication process was implemented using an anion exchan-
ger. Four independent runs resulted on average in 40 mg
plasmid DNA/L culture volume (Figure 1A). However,
somewhat unexpectedly, endotoxin levels up to 50,000
EU/mL do not appear to influence viability, transfection
efficiency nor do they have any marked effect on produc-
tivity. Starting from a basal medium for mammalian cul-
ture, a novel medium which supports both transient
transfection and high titer transient gene expression was
generated in cooperation with Xell AG. Improvements
were achieved by stepwise screening and optimization of
media components with regards to higher cell growth,
transfection efficiency and productivity. The final medium
formulation led to a 4-fold increase in IgG1 productivity
(Figure 1B). To generate an optimized host cell line for
TGE processes, we utilized directed evolution which
resulted in a 3-fold increase in IgG1 productivity in
comparison to the parental host cell line (Figure 1C).
Commonly used transfection reagents such as polyethy-
leneimine (PEI) are quite cytotoxic when used in high
concentrations. As a consequence, the maximum trans-
fectable cell density is limited, since about 0.5 pg DNA/
cell are required during transfection. As a result, similar
levels of production required much larger cell culture
vessels using 25 kDa L-PEI. The newly developed
INVect is a transfection reagent which demonstrates
low cell toxicity for transient transfection of mammalian
cells and leads to extremely high transfection efficien-
cies up to 90%, 24 h post transfection. Finally, the use of
Figure 1 Overview of performed optimizations of TGE parameters. (a) Yield of plasmid preparation for transient transfection. (b) Antibody
quantities (7 day post transfection) expressed by HEK-293 using indicated media. (c) Antibody quantities (7 day post transfection) expressed by
HEK-293 and proprietary HEK-INV. (d) Antibody quantities (7 day post transfection) expressed by HEK-293 using indicated transfection reagent.
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INVect for transfection at TGE conditions resulted in
high levels of protein expression with 2-fold increase
in IgG productivity compared to 25 kDa linear PEI
(Figure 1D).
The combination of all developed aspects allows two
process strategies. On one hand, the low toxicity of
INVect and the performance of the new media system
allow transfection and cultivation at high cell densities
(about 1-4x10E7 cells/mL) achieving antibody titers up
to 850 mg/L (Table 1). On the other hand, it was possi-
ble to establish the first high-yielding pseudo-perfusion
TGE production process at high densities (about 4x10E7
cells/mL) which enables maximum space time yields up
to 200 mg IgG per reactor volume and day.
Conclusions
In conclusion, InVivo’s TGE system includes an
advanced cell line and vector system, a novel transfection
reagent as well as a unique and customized media, all
synergistically optimized for highly efficient production
of recombinant proteins. Applications of this streamlined
process are in early development and lead identification
as well as gram-scale production for pre-clinical trials.
Furthermore, a pseudo-perfusion TGE process was devel-
oped for the production of toxic or labile products such
as enzymes or vaccines. Lastly, a simplified procedure of
the production process using a customized concentrated
feed supplement was implemented which resulted in
antibody titers up to 850 mg/L. Subsequent screenings of
transfection enhancers show promising results and indi-
cate potential for further improvements.
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Table 1. Transient expression of a monoclonal antibody
in independent experiments with differing setups and
scales
Pseudo-perfusion Batch Fed-Batch
Viable cell density 40 x106 cell/mL 5 x106 cell/mL 20 x106 cell/mL
Volume [mL] 10 30-3000 30-300
Duration [days] 10 7 6
Yield [mg/L] 240* 400 850
* final antibody concentration in perfundate
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